Women's Health - Jun 6, 2023 - Can adherence to the Mediterranean diet reduce gestational stress and anxiety in pregnant women?

Can't see this email? View it online

	Women's Health
	The latest women's health news from News Medical

	Can adherence to the Mediterranean diet reduce gestational stress and anxiety in pregnant women? Researchers investigated the influence of structured Mediterranean diet intervention on the anxiety and stress levels.

	Breastfeeding duration associated with improved educational outcomes in later life Children who are breastfed for longer appear to be more likely to gain slightly better results in their school GSCEs at age 16 compared with non-breastfed children, suggests a study published online in the journal Archives of Disease in Childhood.

			Mediterranean diet in pregnancy: A recipe for reduced stress and improved sleep A Mediterranean diet intervention during pregnancy reduces maternal stress and anxiety levels, improves sleep quality, and increases the cortisone/cortisol ratio. These findings highlight the positive impact of dietary changes on maternal well-being during gestation.

			Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases Studies on the long-term consequences of COVID-19 (long-COVID) in patients with inflammatory rheumatic diseases (iRD) are scarce.

	Mother-to-child transmission of SARS-CoV-2: evaluating the association between preventive measures and the risk of infection Researchers evaluated the mother-to-infant transmission rates of SARS-CoV-2.

	Cortisol levels in late pregnancy can predict sleep health of infants Cortisol levels in late pregnancy can predict the sleep of infants, according to a new study to be presented at the SLEEP 2023 annual meeting.

	Study suggests licorice-derived liquiritigenin has breast cancer prevention potential for high-risk postmenopausal women Researchers evaluated the potential of three licorice (Glycyrrhiza) species, i.e., G. glabra (GG), G. uralensis (GU), and G. infata (GI), and hops (Humulus lupulus), and their main bioactive polyphenols, to prevent breast malignancy.

	New collaboration wins award to investigate non-invasive treatment of uterine fibroids A collaboration among Dr. Frank Greenway of Pennington Biomedical Research Center, Dr. Beverly Ogden of Woman's Hospital in partnership with LSU, and the University of Louisiana at Lafayette, was named as one of three award recipients at the Baton Rouge Health-Tech Catalyst Pitch Night.

	Most American Indian/Alaska Native women of childbearing age have suboptimal heart health, AHA reports Heart health risks emerge early in life in American Indian/Alaska Native (AI/AN) women and are increased by social factors -; like high levels of experiencing violence and traumatic life events -; and disproportionately high rates of Type 2 diabetes, smoking and obesity, according to a new scientific statement published today in Circulation: Cardiovascular Quality and Outcomes, a peer-reviewed American Heart Association journal.

	The interplay between variations of menstrual cycle length and age, ethnicity, and body weight Study compares menstrual cycle length with ethnic and body mass characteristics.

	Lipid-degrading enzyme, fatty acid amide hydrolase is a predictor of long-term survival in patients with breast cancer Scientists have identified a lipid-degrading enzyme as a prognostic biomarker for luminal breast cancer.

	CSEM collaborates with innovative Swiss start-up MOMM diagnostics to introduce revolutionary preeclampsia test CSEM’s Tools for Life Sciences team is partnering with MOMM Diagnostics to develop a cutting-edge point-of-care solution for preeclampsia diagnostics. This ground-breaking multiplexed sensing device simultaneously detects two crucial biomarkers associated with this prevalent disease.

	Innovative approach for detecting pre-cancerous lesions using large, high-res images A new study presents an innovative approach to the crucial detection of pre-cancerous lesions using large, high-res images.

	Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.

	ENDO 2023 news conferences to highlight latest research in diabetes, obesity, reproductive health Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society's ENDO 2023 news conferences June 15-18.

	Breast cancer patients experience more severe CIPN symptoms with paclitaxel Chemotherapy-induced peripheral neuropathy (CIPN) – nerve pain, tingling, or numbness in the hands or feet – is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer – the taxanes paclitaxel and docetaxel.

	Evaluating the effects of dietary trends on reproductive outcomes Researchers evaluated the effects of dietary trends on reproductive outcomes.

	Study shows efficacy and safety of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer Updated dose expansion data of the phase I STRO-002-GM1 study have been presented today by Ana Oaknin, Principal Investigator of the Vall d'Hebron Institute of Oncology's (VHIO) Gynecological Malignancies Group, on the ground at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), 2-6 June in Chicago, USA.

	Expertise in cancer treatment could be used to find a cure for endometriosis Endometriosis: If we utilize all the knowledge we have about cancer, there is reason to hope that effective diagnosis and treatments can be developed to combat the female condition 'everybody' is talking about.